 Expanded clinical evaluation lovastatin EXCEL study results II Assessment human lens weeks treatment lovastatin crystalline lenses hypercholesterolemic patients weeks treatment lovastatin placebo effect lovastatin human lens Patients biomicroscopic slit-lamp examination lens classification system findings total patients equal numbers treatment placebo mg twice double-blind parallel-group study Statistical analyses distribution cortical nuclear subcapsular opacities weeks age presence opacity baseline significant differences placebo lovastatin-treated groups Visual acuity assessments week different distributions treatment groups significant differences groups frequencies equal worsening visual acuity concurrent progression lenticular opacity cataract extraction adverse ophthalmologic experience evidence effect lovastatin human lens weeks treatment